Literature DB >> 2372857

A defasciculating dose of d-tubocurarine causes resistance to succinylcholine.

J B Eisenkraft1, M L Mingus, A Herlich, W J Book, A F Kopman.   

Abstract

Forty-four patients, ASA physical status I or II, undergoing thiamylal, fentanyl, N2O/O2 anaesthesia were studied to determine the dose-response to succinylcholine (Sch) without prior defasciculation (24 pt - Group 1), or three minutes following d-tubocurarine (dTC), 0.043 mg.kg-1 (20 pt - Group 2). The individual log dose-logit response curve for each patient was determined using a cumulative dose plus infusion technique and integrated EMG monitoring of the first dorsal interosseous muscle. The mean (+/- SEM) ED50, ED90 and ED95 values for Sch in Group 1 were 0.13 +/- 0.01, 0.19 +/- 0.01 and 0.22 +- 0.01 mg.kg-1, and in Group 2 were 0.16 +/- 0.01, 0.25 +/- 0.01 and 0.29 +/- 0.02 mg.kg-1, respectively. The mean ED values in Group 2 were significantly greater than the equivalent values in Group 1 (P less than 0.05). Compared with values in Group 1, ED values in Group 2 represented mean increases of 23, 32, and 32 per cent, respectively. These pharmacodynamic data indicate that the dose of Sch needs to be increased by 32 per cent following a defasciculating dose of dTC 3 mg.70 kg-1 (0.043 mg.kg-1).

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2372857     DOI: 10.1007/BF03006322

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  14 in total

1.  The pharmacological actions of polymethylene bistrimethyl-ammonium salts.

Authors:  W D M PATON; E J ZAIMIS
Journal:  Br J Pharmacol Chemother       Date:  1949-12

2.  The dose-effect relationship of metocurine: the integrated electromyogram of the first dorsal interosseous muscle and the mechanomyogram of the adductor pollicis compared.

Authors:  A F Kopman
Journal:  Anesthesiology       Date:  1988-04       Impact factor: 7.892

3.  Resistance to succinylcholine in myasthenia gravis: a dose-response study.

Authors:  J B Eisenkraft; W J Book; S M Mann; A E Papatestas; M Hubbard
Journal:  Anesthesiology       Date:  1988-11       Impact factor: 7.892

4.  The need for additional succinylcholine after d-tubocurarine.

Authors:  F G Freund; A P Rubin
Journal:  Anesthesiology       Date:  1972-02       Impact factor: 7.892

5.  The effect of pretreatment with nondepolarizing muscle relaxants on the neuromuscular blocking action of succinylcholine.

Authors:  D J Cullen
Journal:  Anesthesiology       Date:  1971-12       Impact factor: 7.892

6.  The advantages of giving d-tubocurarine before succinylcholine.

Authors:  R D Miller
Journal:  Anesthesiology       Date:  1972-11       Impact factor: 7.892

7.  Dose-response curves for succinylcholine: single versus cumulative techniques.

Authors:  C E Smith; F Donati; D R Bevan
Journal:  Anesthesiology       Date:  1988-09       Impact factor: 7.892

8.  Inhibition of suxamethonium relaxation by tubocurarine and gallamine pretreatment during induction of anaesthesia in man.

Authors:  A L Pauca; R C Reynolds; G E Strobel
Journal:  Br J Anaesth       Date:  1975-10       Impact factor: 9.166

9.  Muscle pains after suxamethonium.

Authors:  O Dottori; B A Löf; H Ygge
Journal:  Acta Anaesthesiol Scand       Date:  1965       Impact factor: 2.105

10.  Pharmacokinetics of succinylcholine in infants, children, and adults.

Authors:  D R Cook; L B Wingard; F H Taylor
Journal:  Clin Pharmacol Ther       Date:  1976-10       Impact factor: 6.875

View more
  2 in total

1.  Remifentanil attenuates muscle fasciculations by succinylcholine.

Authors:  Mi Ja Yun; Yoon Hee Kim; Young Kwon Go; Ji Eun Shin; Choon Gun Ryu; Won Kim; Nam Jong Paik; Moon Ku Han; Sang Hwan Do; Woo Suk Jung
Journal:  Yonsei Med J       Date:  2010-07       Impact factor: 2.759

2.  The effect of defasciculating doses of pancuronium and atracurium on succinylcholine neuromuscular blockade.

Authors:  Cyrus Motamed; Duvaldestin Philippe
Journal:  Anesth Pain Med       Date:  2014-09-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.